Evidence map›Paper›PMID 30692203›Full record

ArticleGenes & development2019

Dppa2 and Dppa4 directly regulate the Dux-driven zygotic transcriptional program.

Mélanie Eckersley-Maslin, Celia Alda-Catalinas, Marloes Blotenburg, Elisa Kreibich, Christel Krueger, Wolf Reik

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 206 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Life medicine · 2025
    Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mélanie Eckersley-MaslinEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom.ORCID 0000-0002-0168-0373
Celia Alda-CatalinasEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom.ORCID 0000-0001-7344-7290
Marloes BlotenburgEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom.
Elisa KreibichEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom.ORCID 0000-0002-9612-1864
Christel KruegerEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom.ORCID 0000-0001-5601-598X
Wolf ReikEpigenetics Programme, Babraham Institute, Cambridge CB22 3AT, United Kingdom.ORCID 0000-0003-0216-9881
Babraham Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K010867/1Wellcome TrustWellcome Trust 095645/Z/11/Z
6 · The paper itself

Abstract

The molecular regulation of zygotic genome activation (ZGA) in mammals remains an exciting area of research. Primed mouse embryonic stem cells contain a rare subset of "2C-like" cells that are epigenetically and transcriptionally similar to the two-cell embryo and thus represent an in vitro approximation for studying ZGA transcription regulation. Recently, the transcription factor Dux, expressed in the minor wave of ZGA, was described to activate many downstream ZGA transcripts. However, it remains unknown what upstream maternal factors initiate ZGA in either a Dux-dependent or Dux-independent manner. Here we performed a candidate-based overexpression screen, identifying, among others, developmental pluripotency-associated 2 (Dppa2) and Dppa4 as positive regulators of 2C-like cells and transcription of ZGA genes. In the germline, promoter DNA demethylation coincides with expression of Dppa2 and Dppa4, which remain expressed until embryonic day 7.5 (E7.5), when their promoters are remethylated. Furthermore, Dppa2 and Dppa4 are also expressed during induced pluripotent stem cell (iPSC) reprogramming at the time that 2C-like transcription transiently peaks. Through a combination of overexpression, knockdown, knockout, and rescue experiments together with transcriptional analyses, we show that Dppa2 and Dppa4 directly regulate the 2C-like cell population and associated transcripts, including Dux and the Zscan4 cluster. Importantly, we teased apart the molecular hierarchy in which the 2C-like transcriptional program is initiated and stabilized. Dppa2 and Dppa4 require Dux to initiate 2C-like transcription, suggesting that they act upstream by directly regulating Dux. Supporting this, ChIP-seq (chromatin immunoprecipitation [ChIP] combined with high-throughput sequencing) analysis revealed that Dppa2 and Dppa4 bind to the Dux promoter and gene body and drive its expression. Zscan4c is also able to induce 2C-like cells in wild-type cells but, in contrast to Dux, can no longer do so in Dppa2/4 double-knockout cells, suggesting that it may act to stabilize rather than drive the transcriptional network. Our findings suggest a model in which Dppa2/4 binding to the Dux promoter leads to Dux up-regulation and activation of the 2C-like transcriptional program, which is subsequently reinforced by Zscan4c.

Indexed as

ZygoteAnimalsChromatinDNA MethylationEmbryonic DevelopmentEmbryonic Stem CellsEpigenesis, GeneticGene Expression Regulation, DevelopmentalGene Knockdown TechniquesGenomeHomeodomain ProteinsMiceNuclear ProteinsPromoter Regions, GeneticTranscription FactorsChromatinDppa2 protein, mouseDppa4 protein, mouseDuxbl protein, mouseHomeodomain ProteinsNuclear ProteinsTranscription Factors2C-like cellsDNA methylationDppa2Dppa4Duxembryonic stem cellepigeneticZscan4zygotic genome activation

Identifiers

PMID30692203
PMCPMC6362816
OpenAlexW2892799402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.